Selonsertib (GS-4997)

Name: Selonsertib (GS-4997); MyBioSource
Brand: MyBioSource
SKU: MBS3601920
Price: 250 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3601920

Selonsertib (GS-4997) is a highly selective and potent, ATP-competetive inhibitor of ASK1 (Apoptosis Signal-regulating Kinase 1, MAP3K5) with potential anti-inflammatory, antineoplastic and anti-fibrotic activities; orally bioavailable. More details

$250 / 5 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Selonsertib, Biochemical

Full Product Name

Selonsertib

Product Synonym Names

GS-4997; GS4997; GS 4997

Purity/Purification

>98% (HPLC)

Preparation and Storage

Store at -20 degree C
Stability: >=2 years
Shipping: Ice Pack

Molecular Weight

445.4921

Suitability

DMSO: >=31mg/mL

Target

MEK

Receptor

ASK1

Chemical Name

Benzamide, 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-[6-[4-(1-methylethyl)-4H-1, 2, 4-triazol-3-yl]-2-pyridinyl]

SMILES

CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F

Molecular Formula

C24H24FN7O

CAS Number

1448428-04-3

Product Categories/Family for Selonsertib biochemical

Steatohepatitis; MAPK/ERK Signaling; Other Indications

Product References and Citations for Selonsertib biochemical

1. Lin JH, et al. Nephron. 2015; 129 (1):29-33.

Other Notes

Small volumes of Selonsertib biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Selonsertib purchase

MBS3601920 is a biochemical targeting Selonsertib.